BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27717107)

  • 1. Management of patients with ocular manifestations in vesiculobullous disorders affecting the mouth.
    Hansen MS; Klefter ON; Julian HO; Lynge Pedersen AM; Heegaard S
    Oral Dis; 2017 Oct; 23(7):849-853. PubMed ID: 27717107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of ocular involvement in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: french national audit of practices, literature review, and consensus agreement.
    Thorel D; Ingen-Housz-Oro S; Royer G; Delcampe A; Bellon N; Bodemer C; Welfringer-Morin A; Bremond-Gignac D; Robert MP; Tauber M; Malecaze F; Dereure O; Daien V; Colin A; Bernier C; Couret C; Vabres B; Tetart F; Milpied B; Cornut T; Ben Said B; Burillon C; Cordel N; Beral L; de Prost N; Wolkenstein P; Muraine M; Gueudry J
    Orphanet J Rare Dis; 2020 Sep; 15(1):259. PubMed ID: 32962748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pemphigus and pemphigoids.
    López-Jornet P; Bermejo-Fenoll A
    Med Oral Patol Oral Cir Bucal; 2005; 10(5):410-1. PubMed ID: 16264376
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between cancer and immunosuppressive therapy--analysis of selected studies in pemphigus and pemphigoid.
    Mabrouk D; Gürcan HM; Keskin DB; Christen WG; Ahmed AR
    Ann Pharmacother; 2010 Nov; 44(11):1770-6. PubMed ID: 20923942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
    De Rojas MV; Dart JK; Saw VP
    Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic mucosynechial pemphigoid: so-called ocular pemphigus].
    Zingirian M
    Adv Ophthalmol; 1976; 32():134-94. PubMed ID: 133599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucous Membrane Pemphigoid: A Case Report with Oral and Ocular Presentation.
    Fageeh HI
    J Contemp Dent Pract; 2022 Jul; 23(7):755-759. PubMed ID: 36440525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy.
    Buonavoglia A; Leone P; Dammacco R; Di Lernia G; Petruzzi M; Bonamonte D; Vacca A; Racanelli V; Dammacco F
    Autoimmun Rev; 2019 Apr; 18(4):349-358. PubMed ID: 30738958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune bullous dermatoses in the elderly: diagnosis and management.
    Mutasim DF
    Drugs Aging; 2003; 20(9):663-81. PubMed ID: 12831291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome.
    Sotozono C; Ang LP; Koizumi N; Higashihara H; Ueta M; Inatomi T; Yokoi N; Kaido M; Dogru M; Shimazaki J; Tsubota K; Yamada M; Kinoshita S
    Ophthalmology; 2007 Jul; 114(7):1294-302. PubMed ID: 17475335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson Syndrome.
    Gregory DG
    Ophthalmology; 2016 Aug; 123(8):1653-1658. PubMed ID: 27297404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral mucous membrane pemphigoid and pemphigus vulgaris-a retrospective two-center cohort study.
    Sultan AS; Villa A; Saavedra AP; Treister NS; Woo SB
    Oral Dis; 2017 May; 23(4):498-504. PubMed ID: 28084005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications].
    Messmer EM; Hintschich CR; Partscht K; Messer G; Kampik A
    Ophthalmologe; 2000 Feb; 97(2):113-20. PubMed ID: 10734737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aspects of corticoid therapy in patients with pemphigus and pemphigoid in the oral cavity].
    Slivka T
    Sb Lek; 1990 Sep; 92(8-9):258-61. PubMed ID: 2237246
    [No Abstract]   [Full Text] [Related]  

  • 15. Cicatricial pemphigoid (mucous membrane pemphigoid): current and emerging therapeutic approaches.
    Sacher C; Hunzelmann N
    Am J Clin Dermatol; 2005; 6(2):93-103. PubMed ID: 15799681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Dry Eye Severity and Ocular Surface Inflammation in Patients with Pemphigus and Pemphigoid.
    Feng J; Liu Y; Ren Y; Shi W; Kang H; Tan Y; Wu R; Zhang G; He Y
    Ocul Immunol Inflamm; 2024 Jan; 32(1):62-70. PubMed ID: 36637982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome.
    Chan LS; Soong HK; Foster CS; Hammerberg C; Cooper KD
    JAMA; 1991 Sep; 266(11):1543-6. PubMed ID: 1880886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unrecognized cicatricial pemphigoid with oral manifestations and ocular complications. A case report.
    Lugović L; Buljan M; Situm M; Poduje S; Bulat V; Vucić M; Budimir J
    Acta Dermatovenerol Croat; 2007; 15(4):236-42. PubMed ID: 18093453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular involvement in autoimmune bullous diseases.
    Kurzeja M; Olszewska M; Grzybowski A; Rudnicka L
    Clin Dermatol; 2023; 41(4):481-490. PubMed ID: 37586570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case series of ocular involvement in bullous pemphigoid: clinical features, management, and outcomes.
    Kate A; Shanbhag S; Donthineni PR; Basu S
    F1000Res; 2021; 10():1201. PubMed ID: 35136583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.